Third Peer-Reviewed Study Proves Botanical Formula Fights Prostate Cancer ... - MarketWatch (press release)

Third Peer-Reviewed Study Proves Botanical Formula Fights Prostate Cancer ... MarketWatch (press release) 8, 2012 /PRNewswire via COMTEX/ -- Scientists at Indiana University, Methodist Research Institute, study a botanical formula that kills aggressive prostate cancer tumors. Their findings, based on experiments in mice using a human prostate cancer tumor ... and more »

FDA questions Amgen drug for prostate cancer - USA TODAY

USA TODAY

FDA questions Amgen drug for prostate cancer USA TODAY WASHINGTON – Scientists for the Food and Drug Administration say that an Amgen drug slowed the spread of cancer to the bone in men with hard-to-treat prostate cancer, though the drug did not extend life and carried significant side effects. Benefit of Bone Drug in Prostate Cancer in DoubtMedPage Today all 222 news articles »